# iKang Healthcare Group

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/ikang-healthcare-group

- Industry: Healthcare
- Headquarters: Beijing, China
- Website: www.ikanggroup.com
- Total disclosed funding: $30M
- Latest round: Series E (Dec 5, 2007)
- Investors on record: 7

## About

Founded in 2004 and based in Beijing, China, iKang Guobin Healthcare Group, Inc., trading as iKang Healthcare Group, operates as a healthcare service company that focuses on providing comprehensive health examination and health management services. Ligang Zhang, the company's founder, chairman and CEO, graduated from Harvard University and has served as product manager and product director of Sohu.com. In April 2014, the company was listed on the NASDAQ.

The company's main business is comprehensive services of physical examination and health management. Relying on its health care service center, IT technology platform and user information integration system, it provides individuals and groups with health services ranging from health examination, medical treatment, family doctor, chronic disease management, health insurance, etc. Its brands include Aikang Dental, Aikang Zhuoyue, Aikang Clinic, etc.

The company generates revenue by providing health examination and health management services.

## Funding rounds

- Series E, Dec 5, 2007, $25M — Walden Catalyst, ePlanet Capital, WI Harper Group, Zero2IPO Ventures, TPG NewQuest, Merrill Lynch Ventures, Shanghai Venture Capital
- Series B, Sep 1, 2006, $3M — WI Harper Group, Shanghai Venture Capital
- Series A, Jan 1, 2006, $2M — WI Harper Group

## Investors

- WI Harper Group (https://capitalatlas.ai/funds/wi-harper-group) — Series A, Series B, Series E
- Shanghai Venture Capital — Series B, Series E
- Walden Catalyst (https://capitalatlas.ai/funds/walden-catalyst) — Series E
- ePlanet Capital (https://capitalatlas.ai/funds/eplanet-capital) — Series E
- Zero2IPO Ventures (https://capitalatlas.ai/funds/zero2ipo-ventures) — Series E
- TPG NewQuest (https://capitalatlas.ai/funds/tpg-newquest) — Series E
- Merrill Lynch Ventures — Series E